TEVA logo

TEVA Free cash flow

annual FCF:

$749.00M-$93.00M(-11.05%)
December 31, 2024

Summary

  • As of today (May 29, 2025), TEVA annual free cash flow is $749.00 million, with the most recent change of -$93.00 million (-11.05%) on December 31, 2024.
  • During the last 3 years, TEVA annual FCF has risen by +$513.00 million (+217.37%).
  • TEVA annual FCF is now -84.30% below its all-time high of $4.77 billion, reached on December 31, 2015.

Performance

TEVA Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAcash flow metrics

quarterly FCF:

-$232.00M-$678.00M(-152.02%)
March 31, 2025

Summary

  • As of today (May 29, 2025), TEVA quarterly free cash flow is -$232.00 million, with the most recent change of -$678.00 million (-152.02%) on March 31, 2025.
  • Over the past year, TEVA quarterly FCF has increased by +$16.00 million (+6.45%).
  • TEVA quarterly FCF is now -115.98% below its all-time high of $1.45 billion, reached on December 31, 2014.

Performance

TEVA quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAcash flow metrics

TTM FCF:

$765.00M+$16.00M(+2.14%)
March 31, 2025

Summary

  • As of today (May 29, 2025), TEVA TTM free cash flow is $765.00 million, with the most recent change of +$16.00 million (+2.14%) on March 31, 2025.
  • Over the past year, TEVA TTM FCF has dropped by -$113.00 million (-12.87%).
  • TEVA TTM FCF is now -85.13% below its all-time high of $5.14 billion, reached on June 30, 2015.

Performance

TEVA TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

TEVA Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-11.1%+6.5%-12.9%
3 y3 years+217.4%-12.6%+30.8%
5 y5 years+235.9%-231.1%+85.2%

TEVA Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-28.1%+217.4%-121.8%+18.3%-44.1%+60.7%
5 y5-year-28.1%+235.9%-121.8%+58.2%-44.1%+684.0%
alltimeall time-84.3%+627.1%-116.0%+58.2%-85.1%+684.0%

TEVA Free cash flow History

DateAnnualQuarterlyTTM
Mar 2025
-
-$232.00M(-152.0%)
$765.00M(+2.1%)
Dec 2024
$749.00M(-11.0%)
$446.00M(-18.2%)
$749.00M(-45.2%)
Sep 2024
-
$545.00M(+8983.3%)
$1.37B(+101.5%)
Jun 2024
-
$6.00M(-102.4%)
$679.00M(-22.7%)
Mar 2024
-
-$248.00M(-123.3%)
$878.00M(+4.3%)
Dec 2023
$842.00M(-19.2%)
$1.06B(-839.6%)
$842.00M(+38.5%)
Sep 2023
-
-$144.00M(-170.2%)
$608.00M(-48.2%)
Jun 2023
-
$205.00M(-172.2%)
$1.17B(+21.7%)
Mar 2023
-
-$284.00M(-134.2%)
$964.00M(-7.5%)
Dec 2022
$1.04B(+341.5%)
$831.00M(+97.4%)
$1.04B(+102.7%)
Sep 2022
-
$421.00M(<-9900.0%)
$514.00M(+8.0%)
Jun 2022
-
-$4.00M(-98.1%)
$476.00M(-18.6%)
Mar 2022
-
-$206.00M(-168.0%)
$585.00M(+147.9%)
Dec 2021
$236.00M(-63.0%)
$303.00M(-20.9%)
$236.00M(+168.2%)
Sep 2021
-
$383.00M(+264.8%)
$88.00M(-167.2%)
Jun 2021
-
$105.00M(-118.9%)
-$131.00M(+39.4%)
Mar 2021
-
-$555.00M(-458.1%)
-$94.00M(-114.7%)
Dec 2020
$638.00M(+186.1%)
$155.00M(-5.5%)
$638.00M(-29.3%)
Sep 2020
-
$164.00M(+15.5%)
$902.00M(+0.9%)
Jun 2020
-
$142.00M(-19.8%)
$894.00M(+116.5%)
Mar 2020
-
$177.00M(-57.8%)
$413.00M(+85.2%)
Dec 2019
$223.00M(-87.6%)
$419.00M(+168.6%)
$223.00M(-631.0%)
Sep 2019
-
$156.00M(-146.0%)
-$42.00M(-150.0%)
Jun 2019
-
-$339.00M(+2507.7%)
$84.00M(-81.3%)
Mar 2019
-
-$13.00M(-108.4%)
$449.00M(-75.0%)
Dec 2018
$1.79B(+32.9%)
$154.00M(-45.4%)
$1.79B(-19.6%)
Sep 2018
-
$282.00M(+984.6%)
$2.23B(-11.9%)
Jun 2018
-
$26.00M(-98.0%)
$2.53B(-7.9%)
Mar 2018
-
$1.33B(+125.2%)
$2.75B(+103.6%)
Dec 2017
$1.35B(-54.8%)
$592.00M(+1.5%)
$1.35B(+161.8%)
Sep 2017
-
$583.00M(+140.9%)
$516.00M(-56.0%)
Jun 2017
-
$242.00M(-466.7%)
$1.17B(-31.8%)
Mar 2017
-
-$66.00M(-72.8%)
$1.72B(-42.5%)
Dec 2016
$2.99B(-37.3%)
-$243.00M(-119.6%)
$2.99B(-35.0%)
Sep 2016
-
$1.24B(+57.4%)
$4.60B(+7.4%)
Jun 2016
-
$788.00M(-34.6%)
$4.28B(-10.9%)
Mar 2016
-
$1.20B(-11.9%)
$4.80B(+0.7%)
Dec 2015
$4.77B(+13.6%)
$1.37B(+48.1%)
$4.77B(-1.8%)
Sep 2015
-
$923.00M(-29.6%)
$4.86B(-5.6%)
Jun 2015
-
$1.31B(+12.1%)
$5.14B(+9.6%)
Mar 2015
-
$1.17B(-19.5%)
$4.69B(+11.8%)
Dec 2014
$4.20B(+90.3%)
$1.45B(+19.8%)
$4.20B(+29.2%)
Sep 2014
-
$1.21B(+40.8%)
$3.25B(+44.2%)
Jun 2014
-
$861.00M(+27.9%)
$2.25B(+10.3%)
Mar 2014
-
$673.00M(+34.1%)
$2.04B(-7.5%)
Dec 2013
$2.21B(-36.4%)
$502.00M(+132.4%)
$2.21B(-25.3%)
Sep 2013
-
$216.00M(-66.8%)
$2.95B(-16.5%)
Jun 2013
-
$650.00M(-22.4%)
$3.54B(-7.5%)
Mar 2013
-
$838.00M(-33.0%)
$3.82B(+10.3%)
Dec 2012
$3.47B(+12.6%)
$1.25B(+56.4%)
$3.47B(+4.2%)
Sep 2012
-
$799.00M(-14.7%)
$3.33B(+21.7%)
Jun 2012
-
$937.00M(+94.4%)
$2.74B(-5.6%)
Mar 2012
-
$482.00M(-56.6%)
$2.90B(-6.0%)
DateAnnualQuarterlyTTM
Dec 2011
$3.08B(-10.1%)
$1.11B(+439.3%)
$3.08B(+8.6%)
Sep 2011
-
$206.00M(-81.2%)
$2.84B(-22.3%)
Jun 2011
-
$1.10B(+64.9%)
$3.65B(+8.3%)
Mar 2011
-
$666.00M(-23.3%)
$3.37B(-1.6%)
Dec 2010
$3.43B(+29.1%)
$868.00M(-14.8%)
$3.43B(+3.7%)
Sep 2010
-
$1.02B(+24.6%)
$3.30B(+6.1%)
Jun 2010
-
$818.00M(+13.5%)
$3.11B(+17.8%)
Mar 2010
-
$721.00M(-3.2%)
$2.64B(-0.5%)
Dec 2009
$2.65B(+4.1%)
$745.00M(-10.1%)
$2.65B(-1.6%)
Sep 2009
-
$829.00M(+138.9%)
$2.70B(+12.4%)
Jun 2009
-
$347.00M(-52.7%)
$2.40B(-10.4%)
Mar 2009
-
$733.00M(-7.0%)
$2.68B(+5.1%)
Dec 2008
$2.55B(+100.6%)
$788.00M(+48.1%)
$2.55B(+18.1%)
Sep 2008
-
$532.00M(-15.0%)
$2.16B(+17.9%)
Jun 2008
-
$626.00M(+3.6%)
$1.83B(+19.5%)
Mar 2008
-
$604.00M(+52.1%)
$1.53B(+20.5%)
Dec 2007
$1.27B(-23.8%)
$397.00M(+94.6%)
$1.27B(-16.4%)
Sep 2007
-
$204.00M(-37.6%)
$1.52B(-24.4%)
Jun 2007
-
$327.00M(-4.7%)
$2.01B(+12.1%)
Mar 2007
-
$343.00M(-46.9%)
$1.79B(+7.6%)
Dec 2006
$1.67B(+57.4%)
$646.50M(-7.0%)
$1.67B(+39.3%)
Sep 2006
-
$695.10M(+529.6%)
$1.20B(+48.8%)
Jun 2006
-
$110.40M(-48.9%)
$804.50M(-23.4%)
Mar 2006
-
$216.00M(+22.8%)
$1.05B(-0.9%)
Dec 2005
$1.06B(+13.4%)
$175.90M(-41.8%)
$1.06B(-9.3%)
Sep 2005
-
$302.20M(-15.2%)
$1.17B(-1.2%)
Jun 2005
-
$356.50M(+58.2%)
$1.18B(+18.2%)
Mar 2005
-
$225.40M(-20.8%)
$1.00B(+7.0%)
Dec 2004
$935.00M(+123.1%)
$284.70M(-10.0%)
$935.00M(+21.1%)
Sep 2004
-
$316.40M(+81.5%)
$771.80M(+44.0%)
Jun 2004
-
$174.30M(+9.2%)
$535.90M(+30.1%)
Mar 2004
-
$159.60M(+31.4%)
$412.00M(-1.7%)
Dec 2003
$419.10M(+116.8%)
$121.50M(+50.9%)
$419.10M(+52.2%)
Sep 2003
-
$80.50M(+59.7%)
$275.40M(+8.1%)
Jun 2003
-
$50.40M(-69.8%)
$254.70M(-10.9%)
Mar 2003
-
$166.70M(-850.9%)
$286.00M(+48.0%)
Dec 2002
$193.30M(+39.0%)
-$22.20M(-137.1%)
$193.30M(-13.2%)
Sep 2002
-
$59.80M(-26.8%)
$222.78M(+12.6%)
Jun 2002
-
$81.70M(+10.4%)
$197.82M(+32.3%)
Mar 2002
-
$74.00M(+916.2%)
$149.49M(+7.5%)
Dec 2001
$139.08M(+82.5%)
$7.28M(-79.1%)
$139.08M(+5.5%)
Sep 2001
-
$34.84M(+4.4%)
$131.80M(+35.9%)
Jun 2001
-
$33.38M(-47.5%)
$96.96M(+52.5%)
Mar 2001
-
$63.59M
$63.59M
Dec 2000
$76.21M(-13.4%)
-
-
Dec 1999
$87.98M(+396.1%)
-
-
Dec 1998
$17.74M(-86.4%)
-
-
Dec 1997
$130.20M(-191.6%)
-
-
Dec 1996
-$142.10M(+822.7%)
-
-
Dec 1995
-$15.40M(-65.3%)
-
-
Dec 1994
-$44.40M(+398.9%)
-
-
Dec 1993
-$8.90M(-60.1%)
-
-
Dec 1992
-$22.30M(+68.9%)
-
-
Dec 1991
-$13.20M
-
-

FAQ

  • What is Teva Pharmaceutical Industries Limited annual free cash flow?
  • What is the all time high annual FCF for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual FCF year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly free cash flow?
  • What is the all time high quarterly FCF for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly FCF year-on-year change?
  • What is Teva Pharmaceutical Industries Limited TTM free cash flow?
  • What is the all time high TTM FCF for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited TTM FCF year-on-year change?

What is Teva Pharmaceutical Industries Limited annual free cash flow?

The current annual FCF of TEVA is $749.00M

What is the all time high annual FCF for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual free cash flow is $4.77B

What is Teva Pharmaceutical Industries Limited annual FCF year-on-year change?

Over the past year, TEVA annual free cash flow has changed by -$93.00M (-11.05%)

What is Teva Pharmaceutical Industries Limited quarterly free cash flow?

The current quarterly FCF of TEVA is -$232.00M

What is the all time high quarterly FCF for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly free cash flow is $1.45B

What is Teva Pharmaceutical Industries Limited quarterly FCF year-on-year change?

Over the past year, TEVA quarterly free cash flow has changed by +$16.00M (+6.45%)

What is Teva Pharmaceutical Industries Limited TTM free cash flow?

The current TTM FCF of TEVA is $765.00M

What is the all time high TTM FCF for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high TTM free cash flow is $5.14B

What is Teva Pharmaceutical Industries Limited TTM FCF year-on-year change?

Over the past year, TEVA TTM free cash flow has changed by -$113.00M (-12.87%)
On this page